PREBOOK THIS REPORT - SAVE 10%

U.S. Clinical Nutrition Market - Industry Outlook & Forecast 2022-2027

TO BE PUBLISHED : Nov 2022 | Pages : 243

THE U.S. CLINICAL NUTRITION MARKET SIZE WAS VALUED AT USD 12.07 BILLION IN 2021 AND IS EXPECTED TO REACH USD 16.63 BILLION BY 2027, GROWING AT A CAGR OF 5.49% DURING THE FORECAST PERIOD

The U.S. Clinical Nutrition Market Size, Share, and Growth Forecast by: 

  • Products: Powder, Liquid, and Semi-Solid
  • Route of Administration: Oral, Enteral Nutrition, and Parenteral Nutrition
  • Age Group: Infant & Toddlers, Children and Teenagers, Adults, and Geriatric
  • Application: Malnutrition, Metabolic Disorders, Gastrointestinal disorders (GI), Cancer, and Others
  • Distribution Channels: Institutional Sales Channels, Supermarkets and Hypermarkets, Pharmacies and Drug Stores, Specialty Stores, Online Channels, and Others
  • End-Users: Hospitals, Individuals, Home care, and Long-term care facilities

Industry Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share, & Forecast 2022-2027

Prebook Tag
Licence Types What are these?
10 % OFF

Save 10% on this report.
Discount already applied

GET ACTIONABLE INSIGHTS ON HOW COVID-19 IS IMPACTING YOUR BUSINESS
Enquire Now Download Free Sample

Most Exhaustive Report

icon-pages

243 Pages

icon-table

56 Tables

icon-chart

144 Charts

icon-region

1 Regions

icon-country

1 Countries

icon-company

25 Companies

icon-market

5 Market Segment

U.S. CLINICAL NUTRITION MARKET REPORT SCOPE

Report Attribute Details
Market Size (2027) USD 16.63 Billion
Market Size (2021) USD 12.07 Billion
CAGR (2022-2027) 5.49%
Base Year 2021
Forecast Year 2022-2027
Market Segments Products, Route of Administration, Age Group, Application, Distribution Channels, and End-Users
KEY VENDORS Abbott, B. Braun Melsungen Ag., Baxter, Danone, Fresenius Kabi, Nestle, Perrigo Company, and Reckitt Benckiser Group

The U.S. clinical nutrition market is expected to grow at a CAGR of 5.49% from 2022 to 2027 and is expected to reach USD 16.63 billion by 2027  from USD 12.07 billion in 2021. The innovation in personalized and targeted clinical nutrition solutions delivers new industry growth opportunities in the U.S. clinical nutrition market. The personalization and targeted solution approach stand with specific formulations that fulfill the need for nutritional support for patients suffering from chronic diseases and associated illnesses. In addition, the COVID-19 pandemic positively influenced the innovation in targeted and personalized clinical nutrition solutions. On another side, the increasing birth rate and the rising demand for milk-based nutritional support products by infants and toddler gives new aspects for vendors in the U.S. clinical nutrition market.

Clinical nutrition, known as medical nutrition, is the practice of analyzing and identifying whether an individual is consuming an adequate amount of nutrients for health. It can also be defined as the study of an overall analysis relationship between ingested meals and the well-being of a person's body. Clinical nutrition prioritizes the management of nutritional adjustment and helps diagnose and prevent nutritional level changes in the human body suffering from chronic conditions.

The U.S. government implements a tremendous breadth and depth of initiatives relevant to the country's nutrition level. So, the increasing government initiatives to improve the country's nutritional health and the rising concern about food insecurity across US families are expected to drive significant U.S. clinical nutrition market growth. In addition, the increasing geriatric population and chronic disease prevalence are constantly fueling industry growth. Obesity, hypertension, gastrointestinal disorders, CVD, and other primary health conditions primely accelerate the country's malnutrition rate, creating a high demand for clinical nutrition. However, there are some limitations to the industry growth, like potential side-effects associated with clinical nutrition and challenges in enteral nutrition deliveries, pediatric ICU patients, and more, hampering the industry growth.

MARKET TRENDS & DRIVERS

Increasing Demand for the Personalized and Targeted Clinical Nutrition
Personalized clinical nutrition is one of the trending approaches in clinical nutrition to fulfill the nutritional demand of every individual patient suffering from specific conditions. The targeted nutrition innovations deliver promising opportunities in medical practices and consumer and food production companies. Innovation in targeted and personalized solutions continues to grow and evolve rapidly in recent years with the increasing consumer demand from food systems to support their health and well-being. In addition, there is an increase in the number of digital tools in the research phase to calculate the nutrition requirement, scan the food based on appearance and help the individuals monitor their nutrition intake. This will further revolutionize the U.S. clinical nutrition market in the future.

Increasing Demand For The Infant Nutrition
One of the significant concerns in infants and toddlers arising rapidly in the US is the low-weight birth rate. About one in 12 babies is born with a low birth rate in the US. Increasing infant birth rates with lower weight delivers significant industry growth opportunities in milk-based nutritional products for U.S. clinical nutrition market players. Milk-based nutritional products are not new in the industry, but increasing demand and high competition among the industry players resulted in innovative product deliveries in recent years.

In 2021, the North American Based Organization Nutricia (by Danone) got approval for the new infant nutrition product Fortini from US FDA. This product is developed to support children living with the risk of growth deficiencies and those with increased energy requirements.

SEGMENTATION ANALYSIS

INSIGHTS BY ROUTE OF ADMINISTRATION
The U.S. clinical nutrition market by route of administration is segmented into oral, enteral, and parenteral, of which the oral segment dominated the industry with a higher share in 2021; due to the higher preference. At homecare, the oral route of administering clinical nutrition solutions is highly preferred among the pediatric population. The oral route of administration accounted for a higher 45.51% industry share.

In 2021, the enteral segment showed dominance over the parenteral segment, with a 36.36% share in the U.S. clinical nutrition market. Enteral nutrition is one of the vital parts of nutrition therapy when the patient cannot meet the nutritional demand by oral intervention. Enteral nutrition is commonly delivered from pediatric to geriatric populations when the patient suffers from gastrointestinal disease.

INSIGHTS BY PRODUCT

The U.S. clinical nutrition market is segmented into powder, liquid, and semi-solid under the products segment. In 2021, the powder product segment accounted for approx. 52% of the U.S. clinical nutrition market share. The high adoption, new product innovation, and higher recommendation by professionals drive significant segmental growth and dominate the other two segments with higher industry share.

The liquid segment in the U.S. clinical nutrition market was valued at USD 3.08 billion in 2021. Liquid form clinical nutrition products deliver enteral and parenteral nutrition therapy. Ready-to-drink is a significant category in the liquid form clinical nutrition product category and is trending in the industry. Their increasing energy drink use in sports and physical activities and rapid energy boosting accelerate high segmental growth.

INSIGHTS BY AGE GROUP
By age group, the infant and toddlers segment shows lucrative opportunities and is growing at a CAGR of 6.61% during the forecast period. The infant and toddler population is a rapidly growing segment in the U.S. clinical nutrition market. Further, the child and teenage segment accounted for a 30.83% industry share and dominated the other segments.

Opportunities for Industry Growth in the US by Child & Teenage 2021

  • In the US high-school students, only 9% meet the daily fruit intake recommendations remaining are some who consume fruits or very low consumption.
  • Only 2% of US children adopt and stick to the recommended vegetable guidelines.
  • The higher consumption of added sugar and unhealthy daily eating habits accounted for children and teenage (2 to 19 age) up to 16% of their total daily calories.

INSIGHTS BY APPLICATION
Malnutrition is one of the major concerns addressed in the US population. Due to the increasing prevalence of various chronic conditions such as obesity/overweight, diabetes, hypertension, GI disorders, CVD, and others led to malnutrition in hospitalized as well as the general population and demand for clinical nutrition. In 2021, the malnutrition segment accounted for a 42.01% higher U.S. clinical nutrition market share and dominated other segments. Currently, more than 40 million US people and around 12 million children are food insure. Many US-based families face poverty and hunger challenges in areas where unprocessed and fresh healthy food is unavailable or sometimes expensive.

Cancer patients are likely to lose weight due to less eating due to stress, pain, diagnosis and treatments, nausea, and test change. Cancer-related malnutrition affects one out of three cancer patients. The U.S. clinical nutrition market by cancer is growing at a CAGR of 6.96% during the forecast period. The demand for good nutrition is significant if the person has cancer due to its illness, and treatments can impact food consumption. Also, cancer treatments impact how the body tolerates certain foods and uses nutrients. If that severe condition appears in the patients, professionals recommend clinical nutrition to the patients and deliver care.

INSIGHTS BY DISTRIBUTION CHANNEL
The U.S. clinical nutrition market by distribution channels is segmented into institutional sales channels, supermarkets and hypermarkets, pharmacies and drug stores, specialty stores, and online sales channels. In 2021, the institutional sales segment accounted for 45.53% industry share in the clinical nutrition market in the US. Institutional sales channels are emerging distribution channels for the clinical nutrition industry, which differ entirely from healthcare practitioner distribution channels. Some industry players came up with unique distribution channels to eliminate the delay and third-party interference in the supply of products.

The supermarket & hypermarket U.S. clinical nutrition market was valued at USD 2.07 billion in 2021. For clinical nutrition, supermarkets and hypermarket are large retail stores operated by self-services that offer milk-based formulas, energy drinks, ready-to-drink, and other clinical nutrition and dietary products recommended by professionals. On the other side, the hypermarket plays a vital role in clinical nutrition products sale. It is one-stop shopping where most of the required clinical nutrition products are available in large amounts, so small retailers or customers can buy them and drive the sale.

INSIGHTS BY END-USER
With the increasing prevalence of malnutrition, metabolic disorders, cancer, GI disorders, and other medical conditions, the hospitalization rate also increased in the US. Hospitals play a vital role in oral, enteral, and parenteral clinical nutrition therapies and contribute to higher industry growth under the end-user segment. In 2021, hospital segments accounted for a 41.95% U.S. clinical nutrition market share. The increasing number of hospital stays led to a rising rate of malnutrition. In the US, millions of people have hospital stays annually and account for malnutrition care which significantly drives the adoption of clinical nutrition therapies in hospitals. The significant demand for oral nutrition supplements (ONS), specifically developed for energy, protein, and other nutrient delivery propels the significant segmental growth.

Homecare is one of the trending healthcare settings widely accepted in the US. After the emergence of the COVID-19 pandemic, most ICU patients and hospitalized patients prefer home nutrition therapies due to their benefits and keep matter with their comfort. Home care nutrition therapies give patients the best environment, showing the rapid recovery of chronically ill patients—the availability of home enteral and parenteral clinical nutrition therapy providers in the US fuel the industry's growth. The homecare U.S. clinical nutrition market is growing at a CAGR of 5.86% during the forecast period.

VENDOR LANDSCAPE

Abbott, B. Braun Melsungen Ag, Baxter, Danone, Fresenius Kabi, Nestle, Perrigo Company, and Reckitt Benckiser Group are the leading players in the U.S. clinical nutrition market players, accounting for the higher industry share in the United States. On the other hand, emerging players and new start-ups are trying to achieve a solid customer base and market expansion. The presence of emerging industry players positively influences the competition in the clinical nutrition market in the US. The primary competition among the industry players accounted due to new product launches, emerging, and gold standard formulations.

Competition Among the Major Industry Players

  • Abbott’s Ensure is one of the leading clinical nutrition products used in the U.S. clinical nutrition market. This product significantly drives the company's high customer base and delivers higher revenue yearly.
  • Danone is a leading industry player offering specialized nutrition comprising Advanced Medical Nutrition (AMN) and Early Life Nutrition solutions.
  • Perrigo Company is one of the leading companies offering store-brand self-care products, including toddler and infant formulas and pediatric and adult nutrition drinks.

Frequently Asked Questions

What is the size of the U.S. clinical nutrition market?

The U.S. clinical nutrition market size was valued at USD 12.07 billion in 2021 and is expected to reach USD 16.63 billion by 2027. The innovation in personalized and targeted clinical nutrition solutions delivers new growth opportunities in the U.S. clinical nutrition market.

What is the projected growth rate of the U.S. clinical nutrition market?

The U.S. clinical nutrition market share is expected to grow at a CAGR of 5.49% from 2022 to 2027.

What are the trends in the U.S. clinical nutrition market?

Innovation in Personalization and Targeted Solutions, Increasing Demand for Infant Nutrition, Advancement in Nutritional Therapies, and Shift Towards Home Nutritional Care are the significant trends in the U.S. clinical nutrition market.

Who are the key players in the U.S. clinical nutrition market?

Abbott, B. Braun Melsungen Ag., Baxter, Danone, Fresenius Kabi, Nestle, Perrigo Company, and Reckitt Benckiser Group are the leading U.S. clinical nutrition market companies.

Which product segment is expected to dominate the U.S. clinical nutrition market?

The powder segment accounted for 51.99% U.S. clinical nutrition market share and dominated the product segment.

Download Free Sample

The U.S. clinical nutrition market is expected to grow at a CAGR of approximately 5.49% from 2022 to 2027.

The following factors are likely to contribute to the growth of the U.S. clinical nutrition market during the forecast period:

  • Government Initiatives, Investments, And Funding for Clinical Nutrition Research
  • Increasing Chronic Diseases Prevalence Required Nutritional Support
  • Impact of COVID-19 On Clinical Nutrition

Base Year: 2021

Forecast Year: 2022-2027

The report considers the present scenario of the U.S. clinical nutrition market and its market dynamics for 2022−2027. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the industry. It also profiles and analyzes leading companies and several other prominent companies operating in the market.

Key Vendors

  • Abbott
    • Business Overview
    • Product Offerings
    • Key Strategies
    • Key Strengths
    • Key Opportunities
  • B. Braun Melsungen Ag.
  • Baxter
  • Danone
  • Fresenius Kabi
  • Nestle
  • Perrigo Company
  • Reckitt Benckiser Group

Other Prominent Vendors

  • ADM
    • Business Overview
    • Product Offerings
  • Ajinomoto Co
  • BASF SE
  • DSM
  • Envara Health
  • Glanbia plc
  • Hero Nutritionals
  • Hum Nutrition
  • Kendal Nutricare
  • Lonza
  • Lactalis Nutrition Santé
  • MEND
  • MediFood International SA
  • Primus Pharmaceuticals
  • SternLife GmbH & Co. KG
  • The Craft Heinz Company
  • Vivante Health

Segmentation by Products

  • Powder
  • Liquid
  • Semi-solid

Segmentation by Route of Administration

  • Oral
  • Enteral nutrition
  • Parenteral Nutrition

Segmentation by Age Group

  • Infant & Toddler
  • Children and teenagers
  • Adult
  • Geriatric

Segmentation by Application

  • Malnutrition
  • Metabolic Disorders
  • Gastrointestinal disorders (GI)
  • Cancer
  • Others

Segmentation by Distribution Channels

  • Institutional Sales Channels
  • Supermarkets and Hypermarkets
  • Pharmacies and Drug Stores
  • Specialty Stores
  • Online Channels
  • Others

Segmentation by End-Users

  • Hospitals
  • Individuals
  • Home care
  • Long-term care facilities

For more details, please reach us at enquiry@arizton.com

For more details, please reach us at enquiry@arizton.com

Select a license type that suits your business needs

single-user Single User Licence
$3750.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email
Best Value Tag
5-user 5 User Licence
$4250.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
corporate.png Corporate Licence
$5250.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
datasheet.png Datasheet Licence
$1500.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Our Clients

Prebook Tag
Licence Types What are these?
10 % OFF

Save 10% on this report.
Discount already applied

Interested in data center portfolio for this report?
Click here

Our Clients Speak

erick

"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."

Erik Young
CEO, Co-founder
Audink Inc., DBA Audios
SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

Click to Email +1-312-235-2040

Want to Customize the Report?

Click Here

Why Arizton?

  • 100% Customer Satisfaction
  • 24x7 availability – we are always there when you need us
  • 200+ Fortune 500 Companies trust Arizton's report
  • 80% of our reports are exclusive and first in the industry
  • 100% more data and analysis
  • 1000+ reports published till date